Achievement of On‑Treatment Remission With Risankizumab in Patients With Moderate‑to‑Severe Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s653, 2025. DOI: 10.25251/1ahmv830. Disponível em: https://skin.dermsquared.com/skin/article/view/3791. Acesso em: 2 may. 2026.